Glaukos Corporation
GKOS
Pozycja w akcjach
#2086
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Cena akcji
$166.79
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$9.84B
Zmiana (1 dzień)
1.44%
Zmiana (1 rok)
109.88%
Kraj
US
Handel Glaukos Corporation (GKOS)
Kategoria
Healthcare
Zyski dla Glaukos Corporation (GKOS)
Zyski w Jun 2026 TTM: $-192.83M
Według najnowszych raportów finansowych Glaukos Corporation, obecny zysk firmy wynosi $-192.83M. W roku 2023 firma osiągnęła zysk w wysokości $-133.73M, spadek w porównaniu do zysku z roku 2022, który wynosił $-98.43M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Glaukos Corporation od 2012 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $-192.83M | 32.44% |
| 2024 | $-145.60M | 8.88% |
| 2023 | $-133.73M | 35.86% |
| 2022 | $-98.43M | 99.79% |
| 2021 | $-49.27M | -62.77% |
| 2020 | $-132.31M | 164.44% |
| 2019 | $-50.04M | 304.56% |
| 2018 | $-12.37M | -1,236,900.00% |
| 2017 | $1.00K | -99.98% |
| 2016 | $4.57M | -111.92% |
| 2015 | $-38.29M | 172.73% |
| 2014 | $-14.04M | -1.28% |
| 2013 | $-14.22M | -35.41% |
| 2012 | $-22.02M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $7.51B | -3,995.08% |
US
|
|
| $5.56B | -2,984.88% |
IE
|
|
| $5.15B | -2,769.67% |
US
|
|
| $3.86B | -2,102.25% |
US
|
|
| - | - |
DE
|
